# Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany

> **NCT05319925** · — · COMPLETED · sponsor: **University Hospital Heidelberg** · enrollment: 213 (actual)

## Conditions studied

- Cancer

## Interventions

- **OTHER:** Patient reported outcome measure

## Key facts

- **NCT ID:** NCT05319925
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-07-31
- **Final completion:** 2023-07-31
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05319925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05319925, "Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05319925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*